Comparison of cisplatin-induced anti-tumor response in CT26 syngeneic tumors of three BALB/c substrains.
Jeong Eun GongYou Jung JinJi Eun KimYun Ju ChoiSu Jin LeeKil Soo KimYoung Suk JungJoon Yong ChoYong LimHyun Gu KangDae Youn HwangPublished in: Laboratory animal research (2021)
Taken together, results of the present study indicate that the genetic background of the three BALB/c substrains has no major effect on the therapeutic responsiveness of cisplatin, except growth and histopathology of the CT26 syngeneic tumor.